A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: deterioration (86), decline (101), degeneration (14), waning (39), setback (1)

Steroid treatment for MS relapse - patient information

Description
This factsheet explains what a multiple sclerosis (MS) relapse is and how steroid medication is used as a treatment.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Steroid-treatment-for-MS-relapse-3052-PIL.pdf

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

Southampton PTC - Approved chemotherapy regimens 9 June 2020

Description
Appendix B: SOUTHAMPTON PAEDIATRIC ONCOLOGY PRINCIPAL TREATMENT CENTRE List of Approved Chemotherapy Regimens Updated 9th June 2020 Revi
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/Southampton-PTC-Approved-chemotherapy-regimens-9-June-2020.pdf

Bendamustine-Polatuzumab-Rituximab

Description
Chemotherapy Protocol LYMPHOMA BENDAMUSTINE-POLATUZUMAB-RITUXIMAB Regimen • Lymphoma – Bendamustine-Polatuzumab-Rituximab Indication • Histolog
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Polatuzumab-Rituximab.pdf

Joan Gavin

Description
Auto Generated Title Congratulations to dietician Joan Gavin, who has been awarded an HEE Wessex Clinical Academic Transitional Award to conduct
Url
/ClinicalResearchinSouthampton/For-researchers/Education-and-training/Careerpathways/Inspirational-career-stories/Joan-Gavin.aspx

Enzalutamide

Description
Chemotherapy Protocol PROSTATE ENZALUTAMIDE Regimen • Prostate-Enzalutamide Indication • Enzalutamide is recommended within its marketing authorisation as an option for treating metastatic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Enzalutamide.pdf

Lenalidomide Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA LENALIDOMIDE There are multiple versions of this protocol in use. Please ensure you have the correct protocol for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lenalidomide-Ver-1.1.pdf

Loncastuximab

Description
Chemotherapy Protocol LYMPHOMA LONCASTUXIMAB TESIRINE Regimen • Diffuse Large B-Cell Lymphoma (DLBCL) / High Grade B-Cell Lymphoma (HGBL) Loncastuximab Tesirine Monotherapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Loncastuximab.pdf

Niraparib

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCERS Regimen NIRAPARIB • Ovarian Cancer – Niraparib Indication • Niraparib is recommended as maintenance tre
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Niraparib.pdf

Cytarabine1500

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (1500mg/m2) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (1500mg/m2) Indication • Consolidation
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine1500.pdf
1 to 10 of 165
Previous 1 2 3 4 5 … Next